Explore more publications!
Africa News Currents
Got News to Share?

Africa News Currents: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Currents.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on January 5, 2026

VAST Data Redesigns AI Inference Architecture for the Agentic Era with NVIDIA
Jan. 5, 2026

VAST Data Redesigns AI Inference Architecture for the Agentic Era with NVIDIA

Indeterminate GlobeNewswire
Trident Resources Engages New Era Publishing Inc. for Corporate Marketing and Investor Awareness Services
Jan. 5, 2026

Trident Resources Engages New Era Publishing Inc. for Corporate Marketing and Investor Awareness Services

Indeterminate GlobeNewswire
Helvetic Clinics Conforte son Statut de Leader Européen du Tourisme Dentaire avec une Croissance de 16% en 2025
Jan. 5, 2026

Helvetic Clinics Conforte son Statut de Leader Européen du Tourisme Dentaire avec une Croissance de 16% en 2025

Indeterminate EIN Presswire
Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference
Jan. 5, 2026

Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Jan. 5, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
Jan. 5, 2026

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
622,590 Units Sold Worldwide: JETOUR Accelerates Its Global Strategy in 2025
Jan. 5, 2026

622,590 Units Sold Worldwide: JETOUR Accelerates Its Global Strategy in 2025

Indeterminate EIN Presswire
CambriLearn Achieves 4.68+ Star Ratings Across All Major Review Platforms, Sets New Transparency Standard
Jan. 5, 2026

CambriLearn Achieves 4.68+ Star Ratings Across All Major Review Platforms, Sets New Transparency Standard

Indeterminate GlobeNewswire
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units
Jan. 5, 2026

Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units

Indeterminate GlobeNewswire
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
Jan. 5, 2026

Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study

Indeterminate GlobeNewswire
ALPHAMIN ANNOUNCES RESIGNATION OF DIRECTOR
Jan. 5, 2026

ALPHAMIN ANNOUNCES RESIGNATION OF DIRECTOR

Indeterminate GlobeNewswire
Nxera Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
Jan. 5, 2026

Nxera Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary
Jan. 5, 2026

Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary

Indeterminate GlobeNewswire
Corvus Pharmaceuticals Confirms Plans to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis in January 2026 Following Annual Healthcare Conference
Jan. 5, 2026

Corvus Pharmaceuticals Confirms Plans to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis in January 2026 Following Annual Healthcare Conference

Indeterminate GlobeNewswire
Kailera Therapeutics Appoints Doug Pagán as Chief Financial Officer
Jan. 5, 2026

Kailera Therapeutics Appoints Doug Pagán as Chief Financial Officer

Indeterminate GlobeNewswire
Kyverna Therapeutics to Present at the J.P. Morgan 2026 Healthcare Conference
Jan. 5, 2026

Kyverna Therapeutics to Present at the J.P. Morgan 2026 Healthcare Conference

Indeterminate GlobeNewswire
Permanent J Code for ZUSDURI™ Now in Effect, Expanding Patient Access to Innovative Bladder Cancer Therapy
Jan. 5, 2026

Permanent J Code for ZUSDURI™ Now in Effect, Expanding Patient Access to Innovative Bladder Cancer Therapy

Indeterminate GlobeNewswire
Electra Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
Jan. 5, 2026

Electra Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Crinetics Announces Strong PALSONIFY Launch Execution and Positive Results for Concurrent Androstenedione Lowering and Glucocorticoid Dose Reduction in Phase 2 Trial of Atumelnant for Congenital Adrenal Hyperplasia
Jan. 5, 2026

Crinetics Announces Strong PALSONIFY Launch Execution and Positive Results for Concurrent Androstenedione Lowering and Glucocorticoid Dose Reduction in Phase 2 Trial of Atumelnant for Congenital Adrenal Hyperplasia

Indeterminate GlobeNewswire
TERRA CLEAN PROVIDES CORPORATE UPDATE AND WELCOMES THE UNITED STATES DEPARTMENT OF ENERGY’S RECENT NEW DOMESTIC NUCLEAR FUEL SUPPLY CHAIN & URANIUM FOCUS
Jan. 5, 2026

TERRA CLEAN PROVIDES CORPORATE UPDATE AND WELCOMES THE UNITED STATES DEPARTMENT OF ENERGY’S RECENT NEW DOMESTIC NUCLEAR FUEL SUPPLY CHAIN & URANIUM FOCUS

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions